1992
DOI: 10.1002/art.1780350123
|View full text |Cite
|
Sign up to set email alerts
|

Liver Enzyme Levels in Arthritis Patients Treated with Long‐Term Bolus Methotrexate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1994
1994
2006
2006

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 2 publications
0
1
0
Order By: Relevance
“…In the last few years, the efforts of clinical investigators have mainly been directed towards two drugs, methotrexate [10][11][12][13] and sulphasalazine [14][15][16][17], which have a favour able effect on the cutaneous and the articular manifestations of PsA. More recently, other compounds (colchicine [18], cyclosporine A [18][19][20], bromocriptine [21], 1,25-dihy droxy vitamin D, [22] and etretinate [23]) have been tested, but their efficacy needs to be confirmed in larger double blind trials.…”
Section: Treatmentmentioning
confidence: 99%
“…In the last few years, the efforts of clinical investigators have mainly been directed towards two drugs, methotrexate [10][11][12][13] and sulphasalazine [14][15][16][17], which have a favour able effect on the cutaneous and the articular manifestations of PsA. More recently, other compounds (colchicine [18], cyclosporine A [18][19][20], bromocriptine [21], 1,25-dihy droxy vitamin D, [22] and etretinate [23]) have been tested, but their efficacy needs to be confirmed in larger double blind trials.…”
Section: Treatmentmentioning
confidence: 99%